Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2005

01-03-2005

Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma

Authors: Antonio Cuadrado, Aitor Orive, Covadonga García-Suárez, Agustín Domínguez, Jose Carlos Fernández-Escalante, Javier Crespo, Fernando Pons-Romero

Published in: Obesity Surgery | Issue 3/2005

Login to get access
Metadata
Title
Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma
Authors
Antonio Cuadrado
Aitor Orive
Covadonga García-Suárez
Agustín Domínguez
Jose Carlos Fernández-Escalante
Javier Crespo
Fernando Pons-Romero
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 3/2005
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1381/0960892053576596

Other articles of this Issue 3/2005

Obesity Surgery 3/2005 Go to the issue

Letter

Extremely High Body Mass Index is Not a Contraindication to Laparoscopic Gastric Bypass?

Letter

Rapid Resolution of Diabetes after Gastric Bypass

OriginalPaper

Empowerment and Self-Management after Weight Loss Surgery

EditorialNotes

Patient Characteristics Impacting Excess Weight Loss following Laparoscopic Adjustable Gastric Banding

EditorialNotes

One-Anastomosis Gastric Bypass by Laparoscopy: Results of the First 209 Patients

EditorialNotes

The Effect of Surgical Weight Reduction on Functional Status in Morbidly Obese Patients with Low Back Pain